Log In
BCIQ
Print this Print this
 

Methylphenidate XR-ODT (Cotempla XR-ODT) (formerly NT-0102)

  Manage Alerts
Collapse Summary General Information
Company Neos Therapeutics Inc.
DescriptionExtended-release oral disintegrating tablet formulation of the generic methylphenidate using Neos' Rapidly Disintegrating Ionic Masking (RDIM) technology
Molecular Target
Mechanism of ActionDopamine and norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat ADHD
Regulatory Designation U.S. - Standard Review (Treat ADHD)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today